Effect of strontium inclusion on the bioactivity of phosphate-based glasses

被引:0
作者
J. K. Christie
N. H. de Leeuw
机构
[1] Loughborough University,Department of Materials
[2] Cardiff University,School of Chemistry
[3] University College London,Department of Chemistry
来源
Journal of Materials Science | 2017年 / 52卷
关键词
Strontium; Dissolution Rate; Phosphate Glass; Strontium Ranelate; Interatomic Potential;
D O I
暂无
中图分类号
学科分类号
摘要
We have conducted first-principles and classical molecular dynamics simulations of various compositions of strontium-containing phosphate glasses, to understand how strontium incorporation will change the glasses’ activity when implanted into the body (bioactivity). To perform the classical simulations, we have developed a new interatomic potential, which takes account of the polarizability of the oxygen ions. The Sr–O bond length is ∼2.44–2.49 Å, and the coordination number is 7.5–7.8. The Qn distribution and network connectivity were roughly constant for these compositions. Sr bonds to a similar number of phosphate chains as Ca does; based on our previous work (Christie et al. in J Phys Chem B 117:10652, 2013), this implies that SrO ↔ CaO substitution will barely change the dissolution rate of these glasses and that the bioactivity will remain essentially constant. Strontium could therefore be incorporated into phosphate glass for biomedical applications.
引用
收藏
页码:9014 / 9022
页数:8
相关论文
共 135 条
[1]  
Nielsen SP(2004)The biological role of strontium Bone 35 583-588
[2]  
Bonnelye E(2008)Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro Bone 42 129-138
[3]  
Chabadel A(2004)The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459-468
[4]  
Saltel F(2005)Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study J Clin Endocrinol Metab 90 2816-2822
[5]  
Jurdic P(2007)Strontium ranelate: new insights into its dual mode of action Bone 40 S5-S8
[6]  
Meunier PJ(2007)Antifracture efficacy of strontium ranelate in postmenopausal osteoporosis Bone 40 S9-S11
[7]  
Roux C(2013)Bactericidal strontium-releasing injectable bone cements based on bioactive glasses J R Soc Interface 10 20120647-813
[8]  
Seeman E(1993)Results of a randomised phase III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer Int J Radiat Oncol Biol Phys 25 805-2401
[9]  
Reginster JY(2003)Phosphate based glasses for biomedical applications J Mater Chem 13 2395-420
[10]  
Seeman E(2013)Bone formation controlled by biologically relevant inorganic ions: role and controlled delivery from phosphate-based glasses Adv Drug Deliv Rev 65 405-2551